MINIMIZATION OF IMMUNOSUPPRESSION IN PRIMARY ADULT LIVER TRANSPLANTATION WITH STEROID-FREE REGIMEN USING LOW DOSE OF TACROLIMUS WITH MYCOPHENOLATE MOFETIL AFTER DACLIZUMAB INDUCTION

被引:0
|
作者
Boillot, Olivier [1 ]
Pittau, Gabriella [1 ]
Dumortier, Jerome [1 ]
Gelas, Thomas [1 ]
Guillaud, Olivier [1 ]
Bouffard, Yves [1 ]
Boucaud, Catherine [1 ]
机构
[1] Edouard Herriot Hosp, Liver Transplant Unit, Lyon, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:240 / 240
页数:1
相关论文
共 50 条
  • [31] Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients
    Yeung, S
    Tsang, WK
    Tong, KL
    Wong, SH
    Lee, W
    Tang, HL
    Chan, HWH
    Chan, AYW
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2084 - 2086
  • [32] Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression
    Flechner, SM
    Friend, PJ
    Brockmann, J
    Ismail, HR
    Zilvetti, M
    Goldfarb, D
    Modlin, C
    Mastroianni, B
    Savas, K
    Devaney, A
    Simmonds, M
    Cook, DJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (12) : 3009 - 3014
  • [33] Randomized trial of triple based immunosuppression using tacrolimus, mycophenolate mofetil and steroids versus quadruple regimen induction with thymoglobulin in liver transplantation.
    Boillot, O
    Poncet, G
    Méchet, I
    Dumortier, J
    Delafosse, B
    Sagnard, P
    Scoazec, JY
    HEPATOLOGY, 2000, 32 (04) : 599A - 599A
  • [34] SAFETY AND EFFICACY OF STEROID-FREE IMMUNOSUPPRESSION POST-LIVER TRANSPLANTATION: A RANDOMISED PHASE III TRIAL COMPARING TACROLIMUS MONOTHERAPY AFTER DACLIZUMAB INDUCTION VERSUS TACROLIMUS plus MMF DUAL THERAPY
    Bilbao, I.
    Otto, G.
    Becker, T.
    D'Amico, D.
    Colledan, M.
    Bernardos, A.
    Beckebaum, S.
    Isoniemi, H.
    Pirenne, J.
    Jaray, J.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S58 - S59
  • [35] Efficacy and safety of Daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression
    Ciancio, G
    Burke, GW
    Suzart, K
    Vaidya, A
    Roth, D
    Kupin, W
    Mattiazzi, A
    Rosen, A
    Esquenazi, V
    Miller, J
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 873 - 874
  • [36] Single Dose of Alemtuzumab Induction With Steroid-Free Maintenance Immunosuppression in Pancreas Transplantation
    Uemura, Tadahiro
    Ramprasad, Varun
    Matsushima, Kazuhide
    Shike, Hiroko
    Valania, Tracy
    Kwon, Osun
    Ghahramani, Nasrollah
    Shah, Riaz
    Farooq, Umar
    Khan, Akhtar
    Kadry, Zakiyah
    TRANSPLANTATION, 2011, 92 (06) : 678 - 685
  • [37] Impact of Change to a Primary Immunosuppression Regimen of Basiliximab, Low Dose Tacrolimus, Mycophenolate and Prednisolone on the Outcome of Kidney Transplantation
    Wan, R. K.
    Mazonakis, M.
    Thomson, L.
    Clancy, M.
    Murio, E.
    Geddes, C. C.
    SCOTTISH MEDICAL JOURNAL, 2009, 54 (03) : 52 - 52
  • [38] Regimen of tacrolimus-based immunosuppression with basiliximab, mycophenolate mofetil, and low-dose steroid reduces acute rejection in kidney transplants
    Hoshinaga, K
    Aikawa, A
    Murai, M
    Yamamoto, H
    Hirayama, N
    Shishido, S
    Hasegawa, A
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1762 - 1763
  • [39] Steroid-free induction with daclizumab and tacrolimus in liver transplant recipients with hepatitis C - A preliminary report.
    Kato, T
    Neff, GW
    Montalbano, M
    Hung, O
    Lavandera, R
    Levi, D
    Nery, J
    Nishida, S
    Reddy, R
    O'Brien, C
    Schiff, ER
    Tzakis, AG
    HEPATOLOGY, 2001, 34 (04) : 362A - 362A
  • [40] Feasibility of steroid-free tacrolimus-basiliximab immunosuppression in pediatric liver transplantation and predictors for steroid requirement
    Renatti, Guido Trezeguet
    Riva, Natalia
    Minetto, Julia
    Reijenstein, Hayellen
    Gole, Maria
    Meza, Veronica
    Bosaleh, Andrea
    Licciardone, Nieves
    Aredes, Diego
    Lauferman, Leandro
    Cervio, Guillermo
    Dip, Marcelo
    Schaiquevich, Paula
    Halac, Esteban
    Imventarza, Oscar
    LIVER TRANSPLANTATION, 2024, 30 (01) : 61 - 71